A digital educational and decision-support intervention for patients with advanced lung cancer receiving immunotherapy: Results of a multi-phase, mixed-methods study.
Randomized trial evaluates a digital application to enhance decision-making in advanced lung cancer, suggesting improved patient engagement.
Key Points
This study aims to develop and evaluate a digital application to support patients with advanced lung cancer receiving immunotherapy in decision-making processes.
Multiphasic, mixed-methods design comprising an online survey (n=186; SPSS)
Semi-structured interviews (n=20; MAXQDA)
Pilot study (n=69) analyzed using Wilcoxon signed-rank test.
App users showed a significant reduction in decisional conflict (median [IQR]: 20.3 pre vs. 10.9 post; p=0.001)
Improvement in knowledge following app usage (p < 0.001)
Increased preparedness for decision-making was also reported.